“Olpha” strengthens its position in Europe with a new generic cardiology medication — AB City

Latvian pharmaceutical manufacturer AS “Olpha” has launched its fourth generic cardiology product within two years. Currently, these medicines produced by AS “Olpha” have entered the pharmaceutical markets of seven European Union (EU) countries, including Latvia, Lithuania, and Estonia.